scholarly journals Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Anusree Sarika ◽  
Anupama Reghu ◽  
Mohammed Salim Karattuthodi ◽  
Aravind Pillai Sreelatha
2020 ◽  
Vol Volume 12 ◽  
pp. 71-83 ◽  
Author(s):  
Gosaye Mekonen Tefera ◽  
Ameha Zewudie Zeleke ◽  
Yitagesu Mamo Jima ◽  
Tsegaye Melaku Kebede

2016 ◽  
Vol 19 (7) ◽  
pp. A824
Author(s):  
MA Nafis ◽  
L D Acharya ◽  
HM Hande

2018 ◽  
Vol 10 (4) ◽  
pp. 460-465 ◽  
Author(s):  
Mohan Greeshma ◽  
Selvan Lincy ◽  
Eswaran Maheswari ◽  
Shankar Tharanath ◽  
Subeesh Viswam

2020 ◽  
Vol 11 (SPL4) ◽  
pp. 366-370
Author(s):  
Kameswari K ◽  
Mohammed Abdul Salaam ◽  
Punita P ◽  
Muthulakshmi R

The main aim of the study is to assess and evaluate the drug related problems in the pulmonology department. It was a Prospective Interventional study in PULMONOLOGY DEPARTMENT conducted at Manipal Super Speciality Hospitals, Vijayawada, Andhra Pradesh for a period of twelve (12) Months from February 2018 to February 2019. We have collected 115 cases from Pulmonology Department. During the study period, we have collected a total number of 115 cases under the pulmonology department. We found that Males are more effected than Females with percentage of 68% (n=78) and 32% (n=37). In the present study 27 DRP’s were found in which 10 Adverse Drug Reactions, 4 Untreated conditions, 4 Inappropriate drug according to guidelines, 4 inappropriate timing of administration, 2 Drug dose too high, 2 No Drug treatment inspite of existing indication, 1 prescribed drug not available. The result of the present Interventional study shows that Clinical pharmacy services helps in identify and resolve drug related harms in discussion with health care professional. In our study we found 27 DRP’s based on PCNE V8.02 classification in which 22 DRP’s were informed to the physician, and 5 DRP’s were identified by the physician. The study shows that there is a need for Clinical Pharmacist services in healthcare to reduce DRP’s by monitoring patient’s drug therapy by which Pharm. D (Doctor of Pharmacy) can be suggested as Clinical Pharmacist since they are well versed in the subject areas like Clinical pharmacy, Clinical Pharmacology, Clinical Toxicology and Pharmacotherapeutics.


Author(s):  
U. KRUTHIKA ◽  
M. SUDHASREE ◽  
J. MOUNIKA ◽  
N. TANDAVA KRISHNA ◽  
M. DIVYA ◽  
...  

Objective: To study the effects of medication reconciliation and patient counseling on the overall health benefits of the patients in the department of gastroenterology. Methods: This study is a prospective interventional study, was conducted in a 500 bedded MNR Hospital. The sample size taken was 150 patients and the study population comprised of patients aged 18-80 y, admitted in the hospital during the study period of six months. Results: Out of 150 patients, there were 98 (65.33%) male patients and 52 (34.67%) female patients. Patients between 18 and 30 y of age were 29(19.33%), between the age of 30 and 50 y were 71 (47.33%) and above 50 were 50(33.33%). Pancreatitis was most prevalent with 21% of total prevalence, followed by CLD and cholelithiasis with 17%, then IBD 16%, PUD and Gastritis 5%, GERD 4% and other diseases 15%. Conclusion: The basic role of the pharmacist, is to help in minimizing the errors and to perform medication reconciliation. In patient counseling, pharmacists provide information about the disease, and the medications to increase patient safety and the changes in the behavior for the better outcome.


Author(s):  
BILESH SHAKYA ◽  
TIRIN BABU ◽  
MOHAMED SHAFI P. ◽  
VEMURI TEJASRI ◽  
JUNY SEBASTIAN ◽  
...  

Objective: To assess the role of clinical pharmacists in the identification and management of drug-induced sexual dysfunction in collaboration with the psychiatrist and also to determine the prevalence and pattern of drug-induced sexual dysfunction, identify nature and extend of drug-induced sexual dysfunction, and assess the pattern of management of drug-induced sexual dysfunction. Methods: This periodic prevalence interventional study was carried out among patients who visited the psychiatric department of a university hospital over three month’s period. Patients were screened for sexual dysfunction using the Arizona Sexual Experience Scale (ASEX) by study pharmacists. Results: Of the 100 patients reviewed, only 50% of subjects met the study criteria. Depression (42%) was the most common clinical diagnosis among the study patients. The overall prevalence of drug-induced sexual dysfunction was 16%. A higher incidence of drug-induced sexual dysfunction was observed in men (62.5%). Decrease libido (40%) was the most prominently observed drug-induced sexual dysfunction in both genders. Antidepressant (50%) was the most common class of drugs implicated in sexual dysfunction. Drug-induced sexual dysfunction was pharmacologically managed with vaginal lubrication (40%), Tadalafil (20%) and Tadalafil+Dapoxetine combination (40%). Conclusion: With this study, provided a vision, further how prospective studies in this arena may be carried out for better understanding drug-induced sexual dysfunction and how a clinical pharmacist can contribute for better health care of patients in the sex clinic by collaborating with medical practitioners.


Author(s):  
Deepishka Pemmasani ◽  
Sai Deepak Gali ◽  
Maanasa Arcot ◽  
Durga Prasad T. S.

Background: Drug-related problems (DRPs) are frequent in hospitalization in pediatrics. The main aim of present investigation is to assess drug related problems and clinical pharmacist interventions in pediatric department of tertiary care hospital.Methods: It was a prospective, observational and interventional study carried over a period of 6 months.Results: A total of 66 patients were identified with drug related problems. Among them 31 (42%) were in between 1month–2 years followed by 25 (34%) were in between 2-11 years, 10(24%) were in between 11-18 years of age. 30(45.3%) patients were prescribed with 0-3 drugs followed by 21 (31.3%) were prescribed with 3-5 drugs, 15(23.3%) were prescribed with 6-10 drugs. Most of the DRP’s observed in the study were drug interactions 52(78.78%) [major-19 (36.53%), moderate-27 (5192%) and minor-6(11.53%)] followed by adverse drug reactions 12 (18.18%), and duplication errors were 2 (3.03%). Majority of the clinical pharmacist recommendations were duration change 52 (34.66%), drug change 10(6.66%), dose reduction 2 (1.35%) followed by drug termination 2 (1.33%). Major significance of DRPs were noted high 31(57.96%), whereas 25 (39.8%) were moderate and 8 (12.12%) were minor. The acceptance rate of intervening clinical pharmacist recommendation and change in drug therapy was found to be high in 57 (86.66%) cases while in 9 (13.33%) cases suggestions were accepted but therapy was not changed. There were no cases with neither suggestion were accepted nor therapy changed.Conclusions: Clinical pharmacist involvement in inpatient pediatric care can significantly help to identify, resolve and prevent the drug related problems. The study concluded that the clinical pharmacist has a significant role in patients care at hospital.


Sign in / Sign up

Export Citation Format

Share Document